Press Releases | Intrexon http://investors.dna.com/ Intrexon Announces Closing of Public Offering of Common Stock and Exercise of Option by Underwriters http://investors.dna.com/2018-01-19-Intrexon-Announces-Closing-of-Public-Offering-of-Common-Stock-and-Exercise-of-Option-by-Underwriters Fri, 19 Jan 2018 10:41:00 -0500 http://investors.dna.com/2018-01-19-Intrexon-Announces-Closing-of-Public-Offering-of-Common-Stock-and-Exercise-of-Option-by-Underwriters Intrexon Prices Public Offering of Common Stock http://investors.dna.com/2018-01-17-Intrexon-Prices-Public-Offering-of-Common-Stock Wed, 17 Jan 2018 09:16:00 -0500 http://investors.dna.com/2018-01-17-Intrexon-Prices-Public-Offering-of-Common-Stock Intrexon Announces Proposed Public Offering of Common Stock http://investors.dna.com/2018-01-16-Intrexon-Announces-Proposed-Public-Offering-of-Common-Stock Tue, 16 Jan 2018 16:15:00 -0500 http://investors.dna.com/2018-01-16-Intrexon-Announces-Proposed-Public-Offering-of-Common-Stock Intrexon's ActoBio Therapeutics to Present at Biotech Showcase 2018 on January 8 http://investors.dna.com/2018-01-04-Intrexons-ActoBio-Therapeutics-to-Present-at-Biotech-Showcase-2018-on-January-8 Thu, 04 Jan 2018 08:35:00 -0500 http://investors.dna.com/2018-01-04-Intrexons-ActoBio-Therapeutics-to-Present-at-Biotech-Showcase-2018-on-January-8 Intrexon to Present at the 36th Annual J.P. Morgan Healthcare Conference http://investors.dna.com/2018-01-04-Intrexon-to-Present-at-the-36th-Annual-J-P-Morgan-Healthcare-Conference Thu, 04 Jan 2018 08:30:00 -0500 http://investors.dna.com/2018-01-04-Intrexon-to-Present-at-the-36th-Annual-J-P-Morgan-Healthcare-Conference